Dong-Ping Chen - JoVE Visualize

Showing results (71-80 of 74) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 74 results.

Cell Research|July 21, 2020

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.

Human Mutation|January 5, 2019

Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcificationXin-Xin Guo, Xiao-Huan Zou, Chong Wang, et al.

The Lancet. Oncology|March 5, 2018

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialLin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.

Lancet (London, England)|February 26, 2023

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialRui You, You-Ping Liu, Yu-Long Xie, et al.

Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 74 results.

Cell Research|July 21, 2020

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.

Human Mutation|January 5, 2019

Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcificationXin-Xin Guo, Xiao-Huan Zou, Chong Wang, et al.

The Lancet. Oncology|March 5, 2018

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialLin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.

Lancet (London, England)|February 26, 2023

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialRui You, You-Ping Liu, Yu-Long Xie, et al.

Pageof 8